References
- Duclos P, Okwo-Bele J-M, Gacic-Dobo M, Cherian T. Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights. 2009;9(S1):S2. doi:10.1186/1472-698X-9-S1-S2.
- Vaccination Calendar for Life. 2019 [accessed 2023 June]. https://www.vaccinarsinveneto.org/assets/uploads/files/250/Calendario_Vaccinale_per_la_Vita_2019.pdf.
- Bonanni P, Angelillo IF, Villani A, Biasci P, Scotti S, Russo R, Maio T, Rosati GV, Barretta M, Bozzola E, et al. Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: let’s avoid adding epidemics to the pandemic: appeal from the board of the vaccination Calendar for life in Italy: maintain and increase coverage also by re-organizing vaccination services and reassuring the population. Vaccine. 2021;39:1187–8. doi:10.1016/j.vaccine.2020.10.024.
- Poscia A, Lo GM, Nigri L, Perone V, Russo R, Bresesti I, Agosti M. Italian immunization calendar implementation: time to optimize number of vaccination appointments? Hum Vaccin Immunother. 2023;19:2156745. doi:10.1080/21645515.2022.2156745.
- Piano Nazionale Prevenzione Vaccinale 2023–2025. [accessed 2023 Sept]. https://www.trovanorme.salute.gov.it/norme/dettaglioAtto.spring?id=95963&page=newsett.
- Ministry of Health. Vaccinazioni dell’età pediatrica. Anno 2021 (coorte 2019). [accessed 2023 June]. https://www.salute.gov.it/imgs/C_17_tavole_20_10_0_file.pdf.
- Bonanni P, Boccalini S, Bechini A, Varone O, Matteo G, Sandri F, Gabutti, G. Co-administration of vaccines: a focus on tetravalent measles-mumps-rubella-varicella (MMRV) and meningococcal C conjugate vaccines. Hum Vaccin Immunother. 2020;16(6):1313–21. doi:10.1080/21645515.2019.1688032.
- Costantino C, Conforto A, Bonaccorso N, Cimino L, Sciortino M, Palermo M, Maiolo K, Tina LG, Betta PM, Caracciolo M, et al. Safety of rotavirus vaccination in preterm infants admitted in neonatal intensive care units in Sicily, Italy: a multicenter observational study. Vaccines (Basel). 2023;11(4):11. doi:10.3390/vaccines11040718.
- Lodi L, Barbati F, Amicizia D, Baldo V, Barbui AM, Bondi A, Costantino C, Da Dalt L, Ferrara L, Fortunato F, et al. Four-component recombinant protein–based vaccine effectiveness against serogroup B meningococcal disease in Italy. JAMA Netw Open. 2023;6(8):e2329678. doi:10.1001/jamanetworkopen.2023.29678.
- E-CDC Scheduler. Portugal: recommended vaccinations. [accessed Sept 2023]. https://vaccine-schedule.ecdc.europa.eu/.
- Martinelli D, Fortunato F, Marchetti F, Prato R. Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence. Hum Vaccin Immunother. 2021;17(5):1546–51. doi:10.1080/21645515.2020.1816109.
- Kite J, Phongsavan P. Insights for conducting real-time focus groups online using a web conferencing service [version 1; peer review: 2 approved with reservations]. F1000Research. 2017;6:122. doi:10.12688/f1000research.10427.2.
- Zafack JG, Bureau A, Skowronski DM, De SG. Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials. BMJ Open. 2019;9(5):e026953. doi:10.1136/bmjopen-2018-026953.
- Bryan P, Seabroke S, Wong J, Donegan K, Webb E, Goldsmith C, Vipond C, Feavers I. Safety of multicomponent meningococcal group B vaccine (4CMenB) in routine infant immunisation in the UK: a prospective surveillance study. Lancet Child Adolesc Health. 2018;2(6):395–403. doi:10.1016/S2352-4642(18)30103-2.
- Bauwens J, de LS, Weldesselassie YG, Sherlock J, Künzli N, Bonhoeffer J. Safety of routine childhood vaccine coadministration versus separate vaccination. BMJ Glob Health. 2022;7(9):e008215. doi:10.1136/bmjgh-2021-008215.
- Giuffrida SC L’esperienza della Regione Calabria sul calendario vaccinale. CME Webinar - 15 April 2023 - The Healthcare Assistant and Vaccinations In a Context Of Continuous Change. 2023 [accessed 2023 June]. https://www.vaccinarsintoscana.org/eventi/2023/15.04.2023-webinar-ecm-l%E2%80%99assistente-sanitario-e-le-vaccinazioni-in-un-contesto-di-cambiamento-continuo.
- Dubus M, Ladhani S, Vasu V. Prophylactic paracetamol after meningococcal B vaccination reduces postvaccination fever and septic screens in hospitalized preterm infants. Pediatr Infect Dis J. 2020;39(1):78–80. doi:10.1097/INF.0000000000002507.
- Ministero della Salute. Piano Nazionale Prevenzione Vaccinale 2017–2019. 2019 [accessed 2023 June]. https://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf.
- Azzari C, Canessa C, Lippi F, Moriondo M, Indolfi G, Nieddu F, Martini M, de Martino M, Castiglia P, Baldo V, et al. Distribution of invasive meningococcal B disease in Italian pediatric population: implications for vaccination timing. Vaccine. 2014;32(10):1187–91. doi:10.1016/j.vaccine.2013.09.055.
- Pellegrino A, Busellu G, Cucchi A, Cavallaro A, Gabutti G. Vaccine co-administration in paediatric age: the experience of the local health unit of cuneo-1 (Ambito di cuneo), Italy. Acta Biomed. 2010;81:204–9.
- UK Health Security Agency. Routine childhood immunisations. [accessed 2023 June]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/465880/9406_PHE_2015_Routine_Childhood_Immunisation_Schedule_12.pdf.
- UK Health Security Agency. The complete routine immunisation schedule from February 2022. [accessed 2023 June]. https://www.gov.uk/government/publications/the-complete-routine-immunisation-schedule/the-complete-routine-immunisation-schedule-from-february-2022.
- EU Clinical Trials Register. 2019-002585-12. [accessed 2023 Sept]. https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-002585-12/IT.
- European Medicines Agency. Guideline on good pharmacovigilance practices (GVP): product- or population-specific considerations IV: paediatric population. [accessed 2023 June]. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-product-population-specific-considerations-iv_en-0.pdf.
- European Medicines Agency. Guideline on good pharmacovigilance practices (GVP) module IX addendum I - methodological aspects of signal detection from spontaneous reports of suspected adverse reaction. [accessed 2023 June]. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-module-ix-addendum-i-methodological-aspects-signal_en.pdf.
- European Medicines Agency. Guideline on good pharmacovigilance practices (GVP) Module IX- Signal management (Rev 1). [accessed 2023 June]. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-module-ix-signal-management-rev-1_en.pdf.
- Marchetti F, Vilca LM, Cetin I. Insights and expectations for Tdap vaccination of pregnant women in Italy. J Matern-Fetal Neo Med. 2021;34(13):2132–9. doi:10.1080/14767058.2019.1659240.
- Vilca LM, Cesari E, Tura AM, Di SA, Vidiri A, Cavaliere AF, Cetin I. Barriers and facilitators regarding influenza and pertussis maternal vaccination uptake: a multi-center survey of pregnant women in Italy. Eur J Obstet Gynecol Reprod Biol. 2020;247:10–15. doi:10.1016/j.ejogrb.2020.02.007.
- Maltezou HC, Wicker S, Borg M, Heininger U, Puro V, Theodoridou M, Poland GA. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine. 2011;29(51):9557–62. doi:10.1016/j.vaccine.2011.09.076.
- Hennink MM, Kaiser BN, Weber MB. What influences saturation? Estimating sample sizes in focus group research. Qual Health Res. 2019;29(10):1483–96. doi:10.1177/1049732318821692.
- Il tuo accesso diretto alla statistica italiana. Resident population: Calabria. [accessed 2023 June]. http://dati.istat.it/index.aspx?queryid=18962.